ALK 或 ROS1 阳性 NSCLC的临床试验
总计35524个结果
-
Consorzio Oncotech完全的
-
Liaoning Tumor Hospital & Institute尚未招聘
-
Goethe University招聘中
-
Shanghai Pharmaceuticals Holding Co., Ltd撤销
-
University Hospital, Essen招聘中
-
Jun Zhang, MD, PhDUniversity of Iowa; University of Kentucky招聘中
-
Addario Lung Cancer Medical InstituteBiodesix, Inc.终止
-
Swiss Group for Clinical Cancer Research主动,不招人
-
National Cancer Center, KoreaHoffmann-La Roche主动,不招人
-
Wolfson Medical Center完全的A Positive or a Negative Brain SPECT以色列
-
Fudan University尚未招聘
-
Peter MacCallum Cancer Centre, Australia招聘中
-
Shanghai Chest HospitalMerck Sharp & Dohme LLC招聘中
-
Radboud University Medical CenterDutch Society of Physicians for Pulmonology and Tuberculosis招聘中
-
Lung Cancer Mutation ConsortiumLung Cancer Research Foundation招聘中
-
Addario Lung Cancer Medical InstituteUniversity of Southern California; Ohio State University Comprehensive Cancer Center招聘中
-
Guangdong Association of Clinical Trials招聘中
-
University of Kansas Medical Centerparkview cancer institute招聘中
-
Theravance Biopharma完全的Serious Infections Due to Known or Suspected Gram-positive Pathogens美国
-
University of Alabama at BirminghamSanofi完全的
-
Daping Hospital and the Research Institute of Surgery...完全的
-
Eucure (Beijing) Biopharma Co., Ltd撤销肝细胞癌 | NSCLC IV期 | 非小细胞肺癌 IIIB 期中国, 澳大利亚, 台湾, 亚美尼亚, 奥地利
-
Samsung Medical CenterCytoGen, Inc.; UNIST (Ulsan National Institute of Science and Technology)主动,不招人NSCLC IV期 | 非小细胞肺癌 IIIB 期大韩民国
-
Hi-Q Marine Biotech International, Ltd.撤销
-
Nested Therapeutics, Inc招聘中胶质瘤 | 黑色素瘤 | 非小细胞肺癌 | 肿瘤学 | 实体瘤,成人 | MEK突变 | RAF基因突变 | Ras(KRAS 或 NRAS)基因突变 | MAPK通路基因突变美国, 澳大利亚
-
Guangzhou Institute of Respiratory DiseaseShanghai Junshi Bioscience Co., Ltd.未知具有 T790M 阳性突变的 IIIb/IV NSCLC 奥希替尼治疗失败中国
-
University of Utah完全的Newly Diagnosed Hormone Positive Clinical Stage 1 or 2 Breast Cancer美国
-
Tongji University招聘中
-
Shenzhen Geno-Immune Medical InstituteThe Seventh Affiliated Hospital of Sun Yat-sen University; Shenzhen Children's Hospital; Shenzhen...招聘中
-
Novartis Pharmaceuticals主动,不招人